key: cord-1045830-26o8xlnf
authors: Huang, Qiuying; Cheng, Yangjian; Guo, Qiwei; Li, Qingge
title: Preparation of a Chimeric Armored RNA as a Versatile Calibrator for Multiple Virus Assays
date: 2006-07-01
journal: Clin Chem
DOI: 10.1373/clinchem.2006.069971
sha: 9f79d13aeeb568c3fa460a2b7ec8f877f370bde6
doc_id: 1045830
cord_uid: 26o8xlnf

nan

had Hb Hoshida (␤43Glu3 Gln). All 4 patients with abnormal peaks at the S window on HPLC (mean retention time, 0.91 min) had Hb Queens (␣1 34Leu3 Arg). All 10 patients with variant peaks were heterozygous, and they had abnormal bands within the Hb S/Hb G/Hb D area on cellulose acetate Hb electrophoresis.

Hb G Coushatta has been found in Koreans, Chinese, and in some Japanese families (6 ) . This variant usually leads to underestimation of Hb A 1c , as we noted in our patients. The abnormal peak between Hb A 1c and Hb A 0 seemed to be that of glycated Hb G Coushatta, as Ogawa et al. (7 ) have indicated, and Hb G Coushatta is thought to coelute with the normal Hb A 0 peak. Hb Hoshida has been reported in a few Japanese families and in 1 Yugoslavian family, and Hb Queens has been found in Koreans, Chinese, Japanese, and Vietnamese (6 ) .

We found increased Hb F concentrations in 15 patients. Gene dosage analysis revealed that the ratios of the ␤-globin gene to the albumin gene were ϳ0.5 in 2 patients, which suggested heterozygous deletion of the ␤-globin gene. One of the 2 patients had no phenotypic abnormality other than the increased Hb F (19.5%), suggesting deletional hereditary persistence of fetal Hb. The other patient had a history of chronic microcytic hypochromic anemia. The increased Hb A 2 concentration, the decreased osmolality fragility, and the typical findings on the peripheral blood smear suggested deletional ␤-thalassemia minor. The remaining 13 patients showed negative results for all molecular analyses on the ␤and ␥-globin genes. Only the XmnI site sequence variation (c.Ϫ158C3 T) on the promoter of the G ␥-globin gene was noted in 10 patients, including 1 homozygote. This sequence variation has been shown to influence the Hb F concentrations in apparently healthy individuals (8 ) .

Hereditary persistence of fetal Hb was suspected because no phenotypic or laboratory abnormalities other than the increased Hb F concentrations were seen.

In conclusion, the incidences of (1) (2) (3) . In detection of RNA viruses, which are often present at low concentrations and are prone to degradation, stringent monitoring is needed for all aspects of assay performance, including virus lysis, RNA isolation, reverse transcription, amplification, and detection steps. Among many proposed RNA control preparations (4, 5 ) , armored RNA is currently the most suitable for clinical applications as it carries the viral RNA target of interest in a form that is ribonuclease-resistant, noninfectious, and stable after prolonged incubation in clinical matrices, and the preparations are substantially less expensive to manufacture than virusinfected plasma (6) (7) (8) . Thus, armored RNA has been applied as a positive control for a variety of RNA viruses (9 ) . Because most commercial armored RNA preparations contain exogenous sequences of Ͻ500 nucleotides (9 ), separate armored RNA species are often prepared for calibration of each target in multiple virus assays. To reduce costs and simplify multivirus detection, we are seeking to produce a single chimeric armored RNA species that might be used as a positive control for multiple viral targets. We consider this task to be feasible because the inventors of armored RNA predicted that, theoretically, at least 2 kb of nonbacteriophage RNA sequence might be encapsulated (8 ) . As proof of this principle, we tried to directly package a 1200-nucleotide-long foreign RNA sequence containing gene fragments of hepatitis C virus (HCV), HIV-1, severe acute respiratory syndrome coronavirus 1 (SARS-CoV1), and SARS-CoV2 into the original armored RNA production vector pAR-1 (8 ) .

We spliced the 4 target cDNA sequences by overlapping extension (10 ) . After cloning the 4-target chimeric sequence (see the Data Supplement that accompanies the online version of this letter at http://www. clinchem.org/content/vol52/issue7/ for the sequence information of the 4 fragments as well as the primers and probes used) into pAR-1, we used a simple but straightforward procedure to confirm the production of armored RNA and to purify it. Briefly, after induction of armored RNA production, we treated the supernatant of Escherichia coli cell lysate with RNase A and DNase I. On testing with agarose gel electrophoresis, if armored RNA was produced, a single DNA band of ϳ1.5 kb might be visible. We then cut the band from the gel and put in a dialysis bag for electroelution. Using this method, we successfully expressed and purified the chimeric armored RNA. We used a pure RNA transcript fragment of SARS-CoV2 (BNI) to calibrate the chimeric armored RNA, then used the chimeric armored RNA to prepare calibrators of the 4 real-time reverse transcription-PCR (RT-PCR) assays ( Fig. 1 ; also see Fig. 1 in the online Data Supplement) based on displacing probes (11 ) . The linear range for each assay did not change when the calibrators were stored at 37°C for 2 weeks, at 4°C for 6 months, or at Ϫ20°C for 1 year.

Our work indicates that multiple target sequences can be encapsulated into a single armored RNA species to serve as a common calibrator for detection of different RNA viruses. Chimeric armored RNA of even larger size may be prepared similarly, as indicated by our finding that by deleting some disposable sequences between the multiple cloning site and the transcription terminator, we were able to increase packaging capacity of the pAR-1 vector without affecting packaging efficiency (data not shown). Thus, the chimeric, multitarget approach for armored RNA preparation is practical and could reduce the labor and cost for quality control of multiplex RNA virus assays.

We thank Xilin Zhao and Karl Drlica for critical comments on the manuscript. This work was partially supported by the Natural Science Foundation of Fujian Government (2003Y004), by the Xiamen Municipal Commission of Science and Technology Key Program, and by the Xiamen University Action Project.

Qiwei Guo Qingge Li * Fig. 1 . Calibration of the real-time RT-PCR assay for HCV, HIV-1, SARS-CoV1, and SARS-CoV2.

We diluted purified and calibrated armored RNA with pooled normal human plasma supplemented with 1 g/L sodium azide and prepared 200-L aliquots by 10-fold serial dilution to obtain samples containing 10 10 to 10 1 copies. From these materials, we isolated template RNA ranging from 10 10 to 10 1 copies (from left to right) for RT-PCR assays. Water was used as a negative control. All RNA templates were assayed in a single run using a diagnostic reagent set (Intec) for each individual virus. Real-time RT-PCR was conducted on an iCycler iQ thermal cycler (Bio-Rad).

To the Editor: Several studies have identified DNA alterations in circulating plasma DNA of cancer patients that match genetic changes in primary tumors, but the low sensitivity obtained has limited the clinical application of plasma analysis (1, 2 ) . A recent report in Clinical Chemistry (3 ) demon-strated that the method chosen to isolate plasma DNA, a modified guanidine/Promega resin (G/R) method, could increase detection of K-ras sequence variations in patients with colorectal disease. Using the same approach, another group (4 ) found no relationship between these isolation methods, nor between K-ras sequence variations found in DNA from plasma and tumor tissue in patients with non-small cell lung cancer. In a previous study (5 ), we found that plasma K-ras analysis was a highly specific, low-sensitivity approach with prognostic significance in pancreatic carcinoma.

To evaluate the agreement rate between K-ras sequence variations in plasma DNA and corresponding tissue, we used the Qiagen method to isolate DNA from 112 plasma samples from patients with pancreatic disease and from 87 plasma samples from patients with colorectal disease. We also isolated DNA from corresponding pancreatic cytology samples and colorectal tissues. The restriction fragment length polymorphism-PCR method used to detect K-ras sequence variations has been described previously (6 ) . The concordant results between plasma and tissue are shown in Table 1 .

In the patients with pancreatic adenocarcinoma, sensitivity for detecting K-ras sequence variations was 43% (19 of 44) in plasma samples and 87% (39 of 45) in fine-needle aspirate or pancreatic juice samples. No sequence variations were detected in plasma DNA from patients with chronic pancreatitis, acute pancreatitis, or other pancreatic neoplasms, giving a specificity of 100%. The agreement rate in pancreatic samples was 78% (19 positive and 67 negative; total, 86 of 110). Single-strand conformation polymorphism (SSCP) analysis allowed characterization of 11 of 19 positive plasma samples, and the spectrum was 8 GAT and 3 GTT. Concordant SSCP results were obtained in plasma and cytology samples. In the colorectal adenocarcinoma group, sensitivity for detecting K-ras sequence variations was 8.5% (7 of 82) in plasma samples and 41% (34 of 82) in resected tissue samples. In colorectal adenomas and diverticulosis, no variant sequences were detected in plasma or tissue. The agreement rate in colorectal plasma and tissue samples was 69% (7 positive and 53 negative; total, 60 of 87). Characterization was possible in 5 of 7 positive plasma samples (3 GAT, 1 GTT, and 1 CGT) and was concordant with results in tissue.

In addition, we performed our routine Qiagen assay method in parallel with the G/R method in a subset of 12 plasma samples (6 pancreatic and 6 colorectal adenocarcinomas) from the evaluated group (3 with the K-ras variant in each group). With the G/R Table 1 . Agreement rate between plasma and pancreatic or colorectal tissue. 

Tests of glycemia in diabetes

Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin

Molecular basis of hereditary persistence of fetal hemoglobin

Rapid detection of point mutations and polymorphisms of the ␣-globin genes by DGGE and SSCA

The Ϫ158 (C3 T) promoter mutation is responsible for the increased transcription of the 3Ј gamma gene in the Atlanta type of hereditary persistence of fetal hemoglobin

HbVar: a relational base of human hemoglobin variants and thalassemia mutations at the globin gene server

Hemoglobin variant HbG-Coushatta (␤-22 Glu3 Ala) found by dissociation of blood glucose from values of HbA1C measured by HPLC

Variation of HbF and F-cell number with the G-␥ Xmn I (C-T) polymorphism in normal individuals

Practical considerations in design of internal amplification controls for diagnostic PCR assays

Novel internal controls for real-time PCR assays

DNA bacteriophage as controls for clinical viral testing

Straightforward procedure for internal control of real-time reverse transcription amplification assays

Stable and noncompetitive RNA internal control for routine clinical diagnostic reverse transcription-PCR

Armored RNA technology for production of ribonuclease-resistant viral RNA controls and standards

Ribonuclease-resistant RNA controls (armored RNA) for reverse transcription-PCR, branched DNA, and genotyping assays for hepatitis C virus

Methods of quantifying viral load in an animal with a ribonuclease resistant RNA preparation

Armored RNA products

Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension

A new class of homogeneous nucleic acid probes based on specific displacement hybridization